Report for: An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial

Title	An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
Published in	Trials, April 2020
DOI	10.1186/s13063-020-4184-8
Pubmed ID	32293527
Authors	Louise F. Hill, Mark A. Turner, Irja Lutsar, Paul T. Heath, Pollyanna Hardy, Louise Linsell, Evelyne Jacqz-Aigrain, Emmanuel Roilides, Mike Sharland

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.

Type	Count	As %
Members of the public	3	60%
Practitioners (doctors, other healthcare professionals)	2	40%

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	69	100%

Readers by professional status	Count	As %
Student > Master	8	12%
Student > Ph. D. Student	8	12%
Student > Doctoral Student	7	10%
Student > Bachelor	6	9%
Other	4	6%
Other	9	13%
Unknown	27	39%

Readers by discipline	Count	As %
Medicine and Dentistry	18	26%
Nursing and Health Professions	10	14%
Pharmacology, Toxicology and Pharmaceutical Science	6	9%
Engineering	2	3%
Sports and Recreations	1	1%
Other	3	4%
Unknown	29	42%

An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (Neo…